RA Capital Management, L.P. added another purchase to its growing tally of insider buys in Artiva Biotherapeutics, Inc. (ARTV), according to a Form 4 filed with the SEC. On July 31, 2026, the investment firm bought 24,944 shares of the clinical-stage biotech at $9.93 apiece, a transaction worth $247,693.92. The purchase was made on the … Read more
RA Capital Management, L.P. added another purchase to its recent run of open-market buys in Artiva Biotherapeutics, Inc. (ARTV), according to a Form 4 filed with the SEC. On July 24, 2026, the investment firm bought 41,319 shares at $9.99 apiece, a purchase worth $412,776.81. Following the transaction, RA Capital’s indirectly held stake stands at … Read more
RA Capital Management, L.P. has been steadily adding to its stake in Artiva Biotherapeutics, Inc. (ARTV), according to a new Form 4 filed with the SEC. The latest purchase, dated July 23, 2026, shows the firm buying 59,880 shares at $9.96 apiece, a transaction worth $596,404.80. This is not an isolated trade. It’s the third … Read more